These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37688949)

  • 1. Efficacy and influencing factor analysis of Voriconazole in the treatment of invasive fungal infections.
    Yang H; Du R; Xing X; Li Y; Qiu B
    Diagn Microbiol Infect Dis; 2023 Nov; 107(3):116047. PubMed ID: 37688949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic administration of voriconazole with two different doses for invasive fungal infection in children and adolescents with acute myeloid leukemia.
    Sano H; Kobayashi R; Hori D; Kishimoto K; Suzuki D; Yasuda K; Kobayashi K
    J Microbiol Immunol Infect; 2018 Apr; 51(2):260-266. PubMed ID: 27329132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observational Study of Associations between Voriconazole Therapeutic Drug Monitoring, Toxicity, and Outcome in Liver Transplant Patients.
    Hashemizadeh Z; Badiee P; Malekhoseini SA; Raeisi Shahraki H; Geramizadeh B; Montaseri H
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voriconazole concentrations and outcome of invasive fungal infections.
    Miyakis S; van Hal SJ; Ray J; Marriott D
    Clin Microbiol Infect; 2010 Jul; 16(7):927-33. PubMed ID: 19845698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis.
    Jin H; Wang T; Falcione BA; Olsen KM; Chen K; Tang H; Hui J; Zhai S
    J Antimicrob Chemother; 2016 Jul; 71(7):1772-85. PubMed ID: 26968880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The application of Voriconazole in 76 patients with cirrhosis at Child-Pugh C stage complicated by invasive fungal infection].
    Zhang Y; Wang YG; Zhang JC; Zhang YT; Liang JX; Mu JS
    Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):137-142. PubMed ID: 33685082
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.
    Job KM; Olson J; Stockmann C; Constance JE; Enioutina EY; Rower JE; Linakis MW; Balch AH; Yu T; Liu X; Thorell EA; Sherwin CM
    Expert Rev Anti Infect Ther; 2016 Aug; 14(8):731-46. PubMed ID: 27355512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring and safety of voriconazole in elderly patients.
    Cheng L; Xiang R; Liu F; Li Y; Chen H; Yao P; Sun F; Xia P
    Int Immunopharmacol; 2020 Jan; 78():106078. PubMed ID: 31830620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Invasive Fungal Infection in Childhood Acute Lymphoblastic Leukemia with Amphotericin B and Voriconazole].
    Yi XL; Mao Q; Jiang Y; Guo XB; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1627-1630. PubMed ID: 29262887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019.
    Jenks JD; Seidel D; Cornely OA; Chen S; van Hal S; Kauffman C; Miceli MH; Heinemann M; Christner M; Jover Sáenz A; Burchardt A; Kemmerling B; Herbrecht R; Steinmann J; Shoham S; Gräber S; Pagano L; Deeren D; Aslam S; Taplitz R; Revankar SG; Baddley J; Mehta SR; Reed S; Slavin MA; Hoenigl M
    Clin Microbiol Infect; 2020 Jun; 26(6):784.e1-784.e5. PubMed ID: 31972317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
    Soler-Palacín P; Frick MA; Martín-Nalda A; Lanaspa M; Pou L; Roselló E; de Heredia CD; Figueras C
    J Antimicrob Chemother; 2012 Mar; 67(3):700-6. PubMed ID: 22190607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients.
    Allegra S; De Francia S; De Nicolò A; Cusato J; Avataneo V; Manca A; Antonucci M; D'Avolio A
    Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):405-412. PubMed ID: 31965553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of voriconazole therapeutic drug monitoring: a meta-analysis.
    Luong ML; Al-Dabbagh M; Groll AH; Racil Z; Nannya Y; Mitsani D; Husain S
    J Antimicrob Chemother; 2016 Jul; 71(7):1786-99. PubMed ID: 27165788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of isavuconazole compared to the standard of care in the treatment of patients with invasive fungal infection prior to differential pathogen diagnosis in the United Kingdom.
    Floros L; Pagliuca A; Taie AA; Weidlich D; Rita Capparella M; Georgallis M; Sung AH
    J Med Econ; 2020 Jan; 23(1):86-97. PubMed ID: 31262225
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimal trough concentration of voriconazole with therapeutic drug monitoring in children: A systematic review and meta-analysis.
    Hanai Y; Hamada Y; Kimura T; Matsumoto K; Takahashi Y; Fujii S; Nishizawa K; Takesue Y
    J Infect Chemother; 2021 Feb; 27(2):151-160. PubMed ID: 33376032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Empiric Voriconazole Dosing and Therapeutic Drug Monitoring in Hospitalized Pediatric Patients.
    Schweiger JA; Heiden AM; MacBrayne CE
    J Pediatr Hematol Oncol; 2024 Aug; 46(6):e419-e425. PubMed ID: 38934583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label trial of the prophylactic administration of voriconazole in patients who undergo allogeneic hematopoietic stem cell transplantation: study protocol.
    Kunitomi A; Hasegawa Y; Hashimoto H; Saito AM; Iida H
    Nagoya J Med Sci; 2018 Nov; 80(4):591-595. PubMed ID: 30587873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal prophylactic effectiveness and intrapulmonary concentrations of voriconazole versus posaconazole in lung transplant recipients.
    Ju C; Lian Q; Chen A; Zhao B; Zhou S; Cai Y; Xie H; Wei L; Li S; He J
    Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36036471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children.
    Allegra S; Fatiguso G; De Francia S; Favata F; Pirro E; Carcieri C; De Nicolò A; Cusato J; Di Perri G; D'Avolio A
    Br J Clin Pharmacol; 2018 Jan; 84(1):197-203. PubMed ID: 28805964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.
    Pepeler MS; Yildiz Ş; Yegin ZA; Özkurt ZN; Tunçcan ÖG; Erbaş G; Köktürk N; Kalkanci A; Yildirim Z
    J Infect Dev Ctries; 2018 Sep; 12(9):799-805. PubMed ID: 31999640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.